Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 15 results when searching "Tofacitinib"

DOCUMENT

07/08/2024 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 07 August 2024 Page 1 of 19 East Region Formulary Committee Minutes Date: 07 August 2024 Time: 2.00pm – 4.45pm Location: MS Teams Present: Carla Capaldi ...

FORMULARY DECISION

Tofacitinib : Xeljanz

SMC2463 : For the treatment of adult patients with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy.

FORMULARY DECISION

Tofacitinib : Xeljanz

1298/18 : In combination with methotrexate for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or mor...

FORMULARY DECISION

Tofacitinib : Xeljanz

SMC2116 : In combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior diseas...

FORMULARY DECISION

Tofacitinib : Xeljanz

SMC2122 : For the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to conventional therapy or a ...